Interferon alfa-2b in renal transplant recipients with viral chronic hepatitis: A pilot study

被引：0
|
作者：
Monteon, FJ
Contreras, AM
Espinoza, L
Vazquez, G
Aguilar, S
Cueva, L
机构：
[1] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,DEPT NEPHROL,GUADALAJARA,JALISCO,MEXICO
[2] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,GUADALAJARA,JALISCO,MEXICO
[3] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,GUADALAJARA,JALISCO,MEXICO
[4] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,DEPT PATHOL,GUADALAJARA,JALISCO,MEXICO
[5] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,DEPT MICROBIOL,GUADALAJARA,JALISCO,MEXICO
来源：
TRANSPLANTATION PROCEEDINGS | 1996年 / 28卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3306 / 3308
页数：3
相关论文
共 50 条
  • [1] Interferon alfa-2b therapy for chronic hepatitis
    Kirchner, JT
    AMERICAN FAMILY PHYSICIAN, 1997, 55 (07) : 2434 - 2434
  • [2] Treatment of chronic hepatitis B and hepatitis C with interferon alfa-2b
    Molloy, PJ
    Azzouz, M
    VanThiel, DH
    AMERICAN FAMILY PHYSICIAN, 1996, 54 (05) : 1598 - 1602
  • [3] Treatment with combination peginterferon alfa-2b and ribavirin of recurrent hepatitis C in liver transplant recipients nonresponsive to interferon alfa-2b and ribavirin
    Samanta, A
    Mandalapu, A
    Fisher, A
    Wilson, D
    de la Torre, A
    Klein, KM
    Koneru, B
    GASTROENTEROLOGY, 2005, 128 (04) : A455 - A456
  • [4] Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C
    Jen, JF
    Glue, P
    Ezzet, F
    Chung, C
    Gupta, SK
    Jacobs, S
    Hajian, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (06) : 407 - 421
  • [5] Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C
    Firpi, RJ
    Abdelmalek, ME
    Soldevila-Pico, C
    Reed, A
    Hemming, A
    Howard, R
    Van der Werf, W
    Lauwers, G
    Liu, C
    Crawford, JM
    Davis, GL
    Nelson, DR
    LIVER TRANSPLANTATION, 2002, 8 (11) : 1000 - 1006
  • [6] A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative
    Sypsa, VA
    Mimidis, K
    Tassopoulos, NC
    Chrysagis, D
    Vassiliadis, T
    Moulakakis, A
    Raptopoulou, M
    Haida, C
    Hatzakis, A
    HEPATOLOGY, 2005, 42 (01) : 77 - 85
  • [7] Impact of pegylated interferon alfa-2b and ribavirin on depression in liver transplant recipients with recurrent hepatitis C
    Challis, M
    Rogge, J
    Weaver, L
    Mukherjee, S
    GASTROENTEROLOGY, 2004, 126 (04) : A699 - A699
  • [8] Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C
    Kraus, Michael R.
    Schaefer, Arne
    Csef, Herbert
    Scheurlen, Michael
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (12) : 1769 - 1774
  • [9] Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C
    Michael R Kraus
    Arne Sch(a|¨)fer
    Herbert Csef
    Michael Scheurlen
    World Journal of Gastroenterology, 2005, (12) : 1769 - 1774
  • [10] Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C
    Schaefer, A
    Scheurlen, M
    Csef, H
    Kraus, MR
    GASTROENTEROLOGY, 2004, 126 (04) : A695 - A695
12345